bluebird bio, Inc. Profile Avatar - Palmy Investing

bluebird bio, Inc.

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of tran…

Biotechnology
US, Cambridge [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
bluebird bio, Inc. can't present any analysts estimates at the moment detail analysis.
End of BLUE's Analysis
CIK: 1293971 CUSIP: 09609G100 ISIN: US09609G1004 LEI: - UEI: -
Secondary Listings
BLUE has no secondary listings inside our databases.